Evoke Pharma, Inc.

Evoke Pharma, Inc. (NASDAQ: EVOK) is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI) diseases. The Company was established by experienced specialty pharmaceutical executives with a successful track record of acquiring, developing, registering, and marketing pharmaceutical products in the US.Evoke has concentrated on the gastroenterology field due to the significant unmet medical needs, the opportunity to improve known products and its focused physician base. Despite the relatively high number of patients suffering from gastrointestinal diseases and disorders, there are only about 12,000 gastroenterologists in the U.S. These physicians conduct over 31 million patient visits and write almost 40 million prescriptions each year valued at $4.8 billion. Also, GI diseases may limit or alter the effectiveness of traditional oral therapies due to the disease for which the product is intended to treat. By developing enhanced versions of currently approved drug products, through novel delivery formats or formulations, Evoke intends to provide patients additional treatment options.

Bank Name Evoke Pharma, Inc.
Stock Exchange NASDAQ
Symbol EVOK
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region America
Chairman
CEO Mr. David A. Gonyer
Employees 7
Website www.evokepharma.com
Registered Year 2007

UpdateContent
UpdateContent
UpdateContent